Bjordal Jan Magnus, Johnson Mark I, Iversen Vegard, Aimbire Flavio, Lopes-Martins Rodrigo Alvaro Brandao
Section of Physiotherapy Science, University of Bergen, Bergen University College, Norway.
Photomed Laser Surg. 2006 Apr;24(2):158-68. doi: 10.1089/pho.2006.24.158.
The aim of this study was to review the biological and clinical short-term effects of photoradiation in acute pain from soft-tissue injury.
It is unclear if and how photoradiation can reduce acute pain.
Literature search of (i) controlled laboratory trials investigating potential biological mechanisms for pain relief and (ii) randomized placebo-controlled clinical trials which measure outcomes within the first 7 days after acute soft-tissue injury.
There is strong evidence from 19 out of 22 controlled laboratory studies that photoradiation can modulate inflammatory pain by reducing levels of biochemical markers (PGE(2), mRNA Cox 2, IL-1beta, TNFalpha), neutrophil cell influx, oxidative stress, and formation of edema and hemorrhage in a dose-dependent manner (median dose 7.5 J/cm(2), range 0.3-19 J/cm(2)). Four comparisons with non-steroidal anti-inflammatory drugs (NSAIDs) in animal studies found optimal doses of photoradiation and NSAIDs to be equally effective. Seven randomized placebo-controlled trials found no significant results after irradiating only a single point on the skin overlying the site of injury, or after using a total energy dose below 5 Joules. Nine randomized placebo-controlled trials (n = 609) were of acceptable methodological quality, and irradiated three or more points and/or more than 2.5 cm(2) at site of injury or surgical incision, with a total energy of 5.0-19.5 Joules. Results in these nine trials were significantly in favor of photoradiation groups over placebo groups in 15 out of 18 outcome comparisons. Poor and heterogeneous data presentation hampered statistical pooling of continuous data. Categorical data of subjective improvement were homogeneous (Q-value = 7.1) and could be calculated from four trials (n = 379) giving a significant relative risk for improvement of 2.7 (95% confidence interval [CI], 1.8-3.9) in a fixed effects model.
photoradiation can modulate inflammatory processes in a dose-dependent manner and can be titrated to significantly reduce acute inflammatory pain in clinical settings. Further clinical trials with adequate photoradiation doses are needed to precisely estimate the effect size for photoradiation in acute pain.
本研究旨在回顾光辐射对软组织损伤急性疼痛的生物学和临床短期影响。
光辐射能否以及如何减轻急性疼痛尚不清楚。
文献检索包括:(i)调查疼痛缓解潜在生物学机制的对照实验室试验;(ii)在急性软组织损伤后7天内测量结果的随机安慰剂对照临床试验。
22项对照实验室研究中的19项有强有力的证据表明,光辐射可通过降低生化标志物(前列腺素E2、mRNA环氧化酶2、白细胞介素-1β、肿瘤坏死因子α)水平、中性粒细胞流入、氧化应激以及水肿和出血的形成,以剂量依赖方式(中位剂量7.5 J/cm²,范围0.3 - 19 J/cm²)调节炎症性疼痛。动物研究中与非甾体抗炎药(NSAIDs)的四项比较发现,光辐射和NSAIDs的最佳剂量同样有效。七项随机安慰剂对照试验发现,仅照射损伤部位上方皮肤的单个点或使用低于5焦耳的总能量剂量后,未得到显著结果。九项随机安慰剂对照试验(n = 609)方法学质量可接受,在损伤部位或手术切口处照射三个或更多点和/或超过2.5 cm²,总能量为5.0 - 19.5焦耳。在这九项试验的18项结果比较中,有15项结果明显有利于光辐射组而非安慰剂组。数据呈现不佳且异质性妨碍了连续数据的统计合并。主观改善的分类数据具有同质性(Q值 = 7.1),可从四项试验(n = 379)中计算得出,在固定效应模型中改善的显著相对风险为2.7(95%置信区间[CI],1.8 - 3.9)。
光辐射可剂量依赖地调节炎症过程,在临床环境中可调整剂量以显著减轻急性炎症性疼痛。需要进一步进行光辐射剂量合适的临床试验,以精确估计光辐射在急性疼痛中的效应大小。